News
A North Texas woman says a new medication treating postpartum depression helped her get through the hardest year of her life.
2d
Zacks Investment Research on MSNWhy Is Sage Therapeutics (SAGE) Down 11.1% Since Last Earnings Report?A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have lost about 11.1% in that time frame, underperforming the S&P 500. Will the recent negative trend ...
Explore This SectionEarthEarth ObserverEditor's CornerFeature ArticlesMeeting SummariesNewsScience in the NewsCalendarsIn ...
The El Dorado County Board of Supervisors honored the winners of the 31st annual SAGE Map Drawing Contest during the May 20 ...
Red Ember Recruitment is seeking to hire a Biometrics System Specialist based in Durban central. The Biometrics System Specialist will oversee the deployment, operation, and integration of biometric ...
Nucleic acid therapeutics are based on nucleic acids or closely related chemical compounds. They include antisense oligonucleotides, aptamers and small interfering RNAs, and are typically ...
I'm getting so frustrated with SAGE50 desktop, it's still the same as 15 years ago, you look at the transactions and there is no drilling option to ...
12d
Medical Device Network on MSNNeuromodulation: rewiring healthcare?Biomed Israel 2025: the 23rd National Life Science & Technology Week is taking place in Tel Aviv between 20 and 22 May.
Florist Parsley and Sage has opened its second Stoke-on-Trent branch. It has opened inside Longton Exchange Shopping Centre from today. It comes as the Parsley and Sage Trentham Road shop remains open ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Viking Therapeutics wasn’t one of them. The 10 stocks that ...
From sculptures of movie characters such as Spiderman and Jar Jar Binks, to a book with mushrooms coming out of it, SAGE Community Arts was filled with artwork by Sheridan ...
Gifting allows recipients to access the article for free. University of Michigan spinout company Courage Therapeutics has raised $7.8 million as part of its seed round, the company announced Friday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results